Podcast: Danger of Tylenol in Opioids; J&J Drug Could Undo Liver Damage — Caused By Its Tylenol

By Cameron English — May 09, 2023
Cutting the dose of Tylenol in opioids makes the drugs safer. Why? Pharma company Johnson & Johnson is developing a drug that could reduce liver damage caused by Tylenol — which J&J also sells.

Cutting the dose of Tylenol in opioids makes the drugs safer. Why? Pharma company Johnson & Johnson is developing a drug that could reduce liver damage caused by Tylenol — which J&J also sells.

Promising Pain Meds in Development: Vertex’s VX-548

By Josh Bloom — May 09, 2023
There's considerable ongoing research to develop analgesic medications that don't have the liabilities of NSAIDs and opioids. Many potential drugs are in various stages of development. Most will fail. This multi-part series will examine drugs in development and their potential utility. First up is VX-458, a Phase III candidate from Vertex.

There's considerable ongoing research to develop analgesic medications that don't have the liabilities of NSAIDs and opioids. Many potential drugs are in various stages of development. Most will fail. This multi-part series will examine drugs in development and their potential utility. First up is VX-458, a Phase III candidate from Vertex.

Farmers at War Over Dicamba

By Susan Goldhaber MPH — May 09, 2023
The use of dicamba, an herbicide, has become an extremely contentious issue in some farm states. It has been accused of “tearing apart the fabric of rural life.” The issues surrounding dicamba present a fascinating study on modern agriculture and problems that arise when technological advances impact farming choices and basic livelihood.

The use of dicamba, an herbicide, has become an extremely contentious issue in some farm states. It has been accused of “tearing apart the fabric of rural life.” The issues surrounding dicamba present a fascinating study on modern agriculture and problems that arise when technological advances impact farming choices and basic livelihood.

Disparities in Care

By Chuck Dinerstein, MD, MBA — May 09, 2023
A new study took as its premise, “Many cancer survivors prefer clinicians who understand or share their culture,” and evaluated how often cancer survivors delayed care based on their income and race. Let’s consider what was found.

A new study took as its premise, “Many cancer survivors prefer clinicians who understand or share their culture,” and evaluated how often cancer survivors delayed care based on their income and race. Let’s consider what was found.

FDA Needs Bold Reforms Instead of Kicking the Can Down the Road

By Henry I. Miller, MS, MD — May 09, 2023
The agency's primary functions are ensuring food safety, regulating tobacco products rationally, and expeditiously approving new drugs and medical devices. It's failing. Instead, we're getting increasingly complex organizational structures and the commissioning of endless reports.

The agency's primary functions are ensuring food safety, regulating tobacco products rationally, and expeditiously approving new drugs and medical devices. It's failing. Instead, we're getting increasingly complex organizational structures and the commissioning of endless reports.

Every Picture Tells a Story: An Algorithm Searches to Be Clinically Useful

By Chuck Dinerstein, MD, MBA — May 08, 2023
Sepsis, an overwhelming infection, remains among hospitals’ most difficult conditions to identify and treat. Algorithms within electronic medical records have been developed to help clinicians. So how is this real-world A.I. of medicine working out? Just a bit better than a coin toss.

Sepsis, an overwhelming infection, remains among hospitals’ most difficult conditions to identify and treat. Algorithms within electronic medical records have been developed to help clinicians. So how is this real-world A.I. of medicine working out? Just a bit better than a coin toss.

Is Poverty a Risk Factor for Dying?

By Chuck Dinerstein, MD, MBA — May 05, 2023
​​​​​​​“Today we are asked to declare war on a domestic enemy which threatens the strength of our nation and the welfare of our people. This administration today, here and now, declares unconditional war on poverty in America.” – Lyndon Johnson, 36th U.S. President, Inaugural Address

​​​​​​​“Today we are asked to declare war on a domestic enemy which threatens the strength of our nation and the welfare of our people. This administration today, here and now, declares unconditional war on poverty in America.”
– Lyndon Johnson, 36th U.S. President, Inaugural Address

The J-Man Chronicles: Roach-Spewing Hand Dryers and Other Atrocities

By Josh Bloom — May 04, 2023
Welcome to another thoroughly worthless edition of the J-Man Chronicles, where you will learn absolutely nothing while at the same time being offended, grossed out, or hopefully both.

Welcome to another thoroughly worthless edition of the J-Man Chronicles, where you will learn absolutely nothing while at the same time being offended, grossed out, or hopefully both.

What I'm Reading (May 4)​​​​​​

By Chuck Dinerstein, MD, MBA — May 04, 2023
Another view of peer review Automating the lawyers As I grow old, I jettison the unnecessary Sleep is not just for humans and other living creatures

Another view of peer review
Automating the lawyers
As I grow old, I jettison the unnecessary
Sleep is not just for humans and other living creatures

High-Tech Medicine and Dentistry Get Headlines. But Low-Tech Innovations Can Save Lives, Cut Healthcare Costs.

By Henry I. Miller, MS, MD — May 04, 2023
High-tech medicine and dentistry can be miraculous but are often hugely expensive. We also need to pursue – and fund – research on ingenious, low-tech, less expensive approaches to improving health and increasing longevity.

High-tech medicine and dentistry can be miraculous but are often hugely expensive. We also need to pursue – and fund – research on ingenious, low-tech, less expensive approaches to improving health and increasing longevity.